Peroxidative and glutathione status in uterus and placenta after normal and pathological pregnancy

Experimental and Toxicologic Pathology

Volumn 49, Issue 6, 1997, Pages 497-500

  Barth, A ^a   Peiker, G ^a   Gross, W ^a   Schroder S ^a   Michels, W ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Glutathione; Lipid peroxidation; Placenta, human; Pregnancy, normal; Pregnancy, pathological; Uterus, human

Indexed keywords

GLUTATHIONE; GLUTATHIONE DISULFIDE; LIPID PEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ARTICLE; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; OXIDATIVE STRESS; PLACENTA; PREGNANCY; PREGNANCY DISORDER; SUPERNATANT; UTERUS;

EID: 0031414380     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0940-2993(97)80150-9     Document Type: Article

References (23)

1. BANERJEE KK, BISHAYEE A, CHATTERJEE M: Elevated lipid peroxidation, decreased glutathione level and changes in glutathione-related enzymes in rats treated with human placental extract. Acta Medica Okayama 1993; 47: 223-227.
2. BARTH A, BERNST M: Influence of bile acids on stimulated lipid peroxidation and hydrogen peroxide production in rat liver microsomes. Exp Toxic Pathol 1992; 44: 399-405.
3. BUEGE JKA, AUST SD: Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-310.
4. DRAPER HH, SQUIRES EJ, MAHMOODI H, et al.: A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radical Biol Med 1993; 15: 353-363.
5. ELLMAN GL: Tissue sulfhydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
6. HISSIN PJ, HILF R: A fluorometric method for determination of oxidized and reduced glutathione in tissues. Anal Biochem 1976; 74: 214-226.
7. HUBEL CA, ROBERTS JN, TAYLOR RN, et al.: Lipid peroxidation in pregnancy: new perspectives on preeclampsia. Am J Obstet Gynecol 1989, 161: 1025-1034.
8. ISHIHARA M: Studies on lipid peroxides of normal pregnant women and of patients with toxemia of pregnancy. Clin Chem Acta 1978; 84: 1-9.
9. KABI BC, GOEL N, RAO YN, et al.: Levels of erythrocyte malonyldialdehyde, vitamin-E, reduced glutathione, G6PD activity and plasma urate in patients of pregnancy induced hypertension. Ind J Med Res 1994; 100: 23-25.
10. KLINGER W, MÜLLER D: The influence of age on protein concentration in serum, liver and kidney of rats determined by various methods. Z Versuchstierk 1974; 16: 19-153.
11. PEIKER G, KRETZSCHMAR M, MÜLLER B, et al.: Changes of thiobarbituric acid reactive substances (TBARS), i. e., glutathione, alpha-tocopherol, selenium, and copper during normal and disturbed pregnancy (pregnancy-induced hypertension). Int J Feto-Maternal Med 1992; 5: 155-159.
12. SASTRE J, ASENSI M, RODRIGO F, et al.: Antioxidant administration to the mother prevents oxidative stress associated with birth in the neonatal rat. Life Sciences 1994; 54: 2055-2059.
13. STRATTA P, CANAVESE C, PORCU M, et al.: Vitamin E supplementation in preeclampsia. Gynecol Obstet Invest 1994; 37: 246-249.
14. TABACOVA S, LITTLE RE, BALABAEVA L, et al.: Complications of pregnancy in relation to maternal lipid peroxides, glutathione, and exposure to metals. Reproductive Toxicol 1994a; 8: 217-224.
15. TABACOVA S, BAIRD DD, BALABAEVA L, et al.: Placental arsenic and cadmium in relation to lipid peroxides and glutathione levels in maternal-infant pairs from a copper smelter area. Placenta 1994b; 15: 873-881.
16. TOMITA M, OKUYAMA T, KAWAI S: Determination of malonaldehyde in oxidized biological materials by high performance liquid chromatography. J Chromatography 1990; 515: 391-397.
17. TRAEGER A, HOFFMANN H, FRANKE H, et al.: The influence of phenobarbital on drug-metabolizing enzymes in the human placenta, on the fine structure of the chorionic villi and on the serum bilirubin concentration in the newborns. Z Geburtsh Perinat 1972; 176: 397-402.
18. WALSH SW: Lipid peroxidation in pregnancy. Hypertension in Pregnancy 1994; 13: 1-32.
19. WALSH SW, WANG YP: Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol 1993a; 169: 1456-1461.
20. WALSH SW, WANG YP: Secretion of lipid peroxides by the human placenta. Am J Obstet Gynecol 1993b; 169: 1462-1466.
21. WALSH SW, WANG YP: Trophoblast and placental villous core production of lipid peroxides, thromboxane, and prostacyclin in preeclampsia. J Clin Endocrinol Metabolism 1995; 80: 1888-1893.
22. WANG YP, WALSH SW: Aspirin inhibits both lipid peroxides and thromboxane in preeclamptic placentas. Free Rad Biol Med 1995; 18: 585-591.
23. YAGI K: Lipid peroxides and human diseases. Chem Phys Lipids 1987; 45: 337-351.